Literature DB >> 26621896

Pulmonary arterial hypertension in patients treated with interferon.

Laurent Savale1, Marie-Camille Chaumais2, Olivier Sitbon3, Marc Humbert3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26621896     DOI： 10.1183/13993003.01376-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

1.  Aicardi goutières syndrome is associated with pulmonary hypertension.

Authors:  Laura A Adang; David B Frank; Ahmed Gilani; Asako Takanohashi; Nicole Ulrick; Abigail Collins; Zachary Cross; Csaba Galambos; Guy Helman; Usama Kanaan; Stephanie Keller; Dawn Simon; Omar Sherbini; Brian D Hanna; Adeline L Vanderver
Journal:  Mol Genet Metab       Date:  2018-09-07       Impact factor: 4.797

2.  Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension.

Authors:  Marie-Camille Chaumais; Caroline O'Connell; Laurent Savale; Christophe Guignabert; Frédéric Perros; Xavier Jaïs; Olivier Sitbon; Marc Humbert; David Montani
Journal:  Int J Clin Pharm       Date:  2018-08-13

3.  Pulmonary arterial hypertension in interferonophaties: a case report and a review of the literature.

Authors:  A Trombetta; S Ghirardo; S Pastore; A Tesser; E Piscianz; A Tommasini; M Bobbo; A Taddio
Journal:  Pulm Circ       Date:  2019-08-09       Impact factor: 3.017

4.  Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease.

Authors:  Laurent Savale; Alessandra Manes
Journal:  Eur Heart J Suppl       Date:  2019-12-17       Impact factor: 1.803
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.